当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Dimitra N Stratis-Cullum and Amethist S Finch
Biosensing technology is not currently capable of widespread use outside of a laboratory environment due to significantly limitation in bioreceptor function and production, as well as in the overall size, weight, and cost of the sensing platform. However, as technology continues to advance, biosensors could truly become ubiquitous, employing social media and personal electronic devices for mundane yet powerful capabilities. In the near future, point-of-care diagnostics in third-world countries could save millions of lives and revolutionize the healthcare industry worldwide. Recent trends show many of the traditional barriers to realizing this vision will soon be overcome. In this paper we review exciting trends in the development of synthetic reagents, fluidic integration, and mobile platforms that are necessary for ubiquitous biosensing capabilities.